GPT and fatty liver disease: Human beta defensin 2 administration significantly attenuated EtOH-induced liver injury in Cohort 1 as shown by reduced ALT levels in EtOH + hBD-2-treated mice compared to EtOH-fed mice (Figure 2A) with a slight decrease in liver steatosis as reflected in H&E staining and as assessed by ORO staining (Figures 2B,C).